
BTIG analyst Ryan Zimmerman maintains Carlsmed (NASDAQ:CARL) with a Buy and raises the price target from $23 to $24.
You can purchase shares of Carlsmed (NASDAQ:CARL) through any online brokerage.
Other companies in Carlsmed’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Carlsmed has a consensus price target of $19.20.
The stock price for Carlsmed (NASDAQ: CARL) is $15 last updated October 30, 2026 at 5:10 PM EDT.
There are no upcoming dividends for Carlsmed.
Carlsmed does not have any upcoming earnings scheduled.
There is no upcoming split for Carlsmed.
Carlsmed is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Carlsmed Inc is a commercial-stage medical technology company focused on developing AI-enabled personalized solutions for spine surgery. The company operates as a single operating and reportable segment engaged in the design, manufacture, and...